We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$111M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow %
97.8%
Top 10 Hldgs %
35.94%
Holding
105
New
105
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$6.57M
2
DAIO icon
Data I/O
DAIO
+$5.31M
3
AMZN icon
Amazon
AMZN
+$4.95M
4
ESIO
Electro Scientific Industries
ESIO
+$4.42M
5
MSFT icon
Microsoft
MSFT
+$4.25M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 26.96%
2 Healthcare 12.66%
3 Energy 10.8%
4 Financials 9.9%
5 Communication Services 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FAX
101
abrdn Asia-Pacific Income Fund
FAX
$595M
$109K 0.1%
+22,300
New +$109K
DALN
102
DELISTED
DallasNews
DALN
$107K 0.1%
+5,594
New +$106K
MCHX icon
103
Marchex
MCHX
$84.2M
$40K 0.04%
+12,500
New +$39.9K
CASM
104
DELISTED
CAS Medical Systems, Inc.
CASM
$26K 0.02%
+33,600
New +$24.6K
1 2 3 4
5

Similar funds

IWM
IMG Wealth Management Jacksonville, Florida $157M AUM 17.95% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
AC
AlpenGlobal Capital Tahoe City, California $157M AUM
SF
Seros Financial Tempe, Arizona $157M AUM 16.95% 1-Year Est. Return
LAM
Lakewood Asset Management Naperville, Illinois $156M AUM 15.91% 1-Year Est. Return
HAM
Harber Asset Management Asheville, North Carolina $156M AUM 2.37% 1-Year Est. Return
HEM
Henson-Edgewater Management Avon, Ohio $157M AUM
CF
CDC Financial Chicago, Illinois $157M AUM

Penbrook Management's Q4 2017 Portfolio in Review

Q4 2017 is the first quarter with a 13F filing on record for Penbrook Management, which disclosed 105 positions worth $111M. Its ten largest holdings account for 36% of the portfolio.

Its largest position is Novo Nordisk: 258,200 shares worth $6.93M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, followed by Healthcare and Energy.

  • Penbrook Management's largest Q4 2017 buy was Novo Nordisk: 258,200 shares worth $6.93M.
  • Penbrook Management's ten largest holdings make up 36% of its $111M portfolio in Q4 2017.
  • Penbrook Management disclosed 105 positions in Q4 2017, its first 13F filing on record.

Based on Penbrook Management's 13F filing for Q4 2017, filed 21 Feb 2018.